JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02138-06v1
81/9/4604    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Billington, J.
Right arrow Articles by Daniels, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Billington, J.
Right arrow Articles by Daniels, R. S.

 Previous Article  |  Next Article 

Journal of Virology, May 2007, p. 4604-4614, Vol. 81, No. 9
0022-538X/07/$08.00+0     doi:10.1128/JVI.02138-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Stability of a Receptor-Binding Active Human Immunodeficiency Virus Type 1 Recombinant gp140 Trimer Conferred by Intermonomer Disulfide Bonding of the V3 Loop: Differential Effects of Protein Disulfide Isomerase on CD4 and Coreceptor Binding{triangledown}

J. Billington,1 T. P. Hickling,1,{dagger} G. H. Munro,1 C. Halai,1 R. Chung,1 G. G. Dodson,2 and R. S. Daniels1*

Virology Division,1 Protein Structure Division, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom2

Received 29 September 2006/ Accepted 8 February 2007

Stable trimeric forms of human immunodeficiency virus recombinant gp140 (rgp140) are important templates for determining the structure of the glycoprotein to assist in our understanding of HIV infection and host immune response. Such information will aid the design of therapeutic drugs and vaccines. Here, we report the production of a highly stable and trimeric rgp140 derived from a HIV type 1 (HIV-1) subtype D isolate that may be suitable for structural studies. The rgp140 is functional in terms of binding to CD4 and three human monoclonal antibodies (17b, b12, and 2G12) that have broad neutralizing activities against a range of HIV-1 isolates from different subtypes. Treatment of rgp140 with protein disulfide isomerase (PDI) severely restricted 17b binding capabilities. The stable nature of the rgp140 was due to the lack of processing at the gp120/41 boundary and the presence of an intermonomer disulfide bond formed by the cysteines of the V3 loop. Further characterization showed the intermonomer disulfide bond to be a target for PDI processing. The relevance of these findings to the roles of the V3 domain and the timing of PDI action during the HIV infection process are discussed.


* Corresponding author. Mailing address: Virology Division, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom. Phone: 44 (0) 20 8816 2139. Fax: 44 (0) 20 8906 4477. E-mail: rdaniel{at}nimr.mrc.ac.uk

{triangledown} Published ahead of print on 14 February 2007.

{dagger} Present address: Microbiology and Infectious Diseases, West Block, Floor A, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom.


Journal of Virology, May 2007, p. 4604-4614, Vol. 81, No. 9
0022-538X/07/$08.00+0     doi:10.1128/JVI.02138-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.